Advances in lupus stemming from the parent-into-F1 model

Trends in Immunology

Volumn 31, Issue 6, 2010, Pages 236-245

  Via, Charles S ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; INTERLEUKIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD40; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS LIKE SYNDROME; MEMORY T LYMPHOCYTE; MOUSE STRAIN; NONHUMAN; REMISSION; REVIEW; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GRAFT VS HOST DISEASE; HUMANS; IMMUNOLOGIC MEMORY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

EID: 77952973583     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.02.001     Document Type: Review

References (77)

1. Gleichmann E., et al. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 5 (1984) 324-332
2. Via C.S., and Shearer G.M. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9 (1988) 207-213
3. Portanova J.P., and Kotzin B.L. Lupus-like autoimmunity in murine graft-versus-host disease. Concepts Immunopathol. 6 (1988) 119-140
4. Eisenberg R. The chronic graft-versus-host model of systemic autoimmunity. Curr. Dir. Autoimmun. 6 (2003) 228-244
5. Puliaev R., et al. CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J. Immunol. 181 (2008) 47-61
6. Puliaeva I., et al. Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE. Autoimmun. Rev. 8 (2009) 219-223
7. Morris S.C., et al. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171 (1990) 503-517
8. Gleichmann E., et al. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12 (1982) 152-159
9. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 1725
10. Gleichmann E., and Gleichmann H. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J. Invest. Dermatol. 85 (1985) 115s-120s
11. Rolink A.G., et al. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis. J. Immunol. 130 (1983) 209-215
12. van Elven E.H., et al. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. II. Autoantibodies deposited along the basement membrane of skin and their relationship to immune-complex glomerulonephritis. J. Immunol. 126 (1981) 1684-1691
13. Van der Veen F., et al. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. IV. Autoantibodies to nuclear antigens. Clin. Exp. Immunol. 46 (1981) 589-596
14. Grader-Beck T., et al. Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus. J. Immunol. 178 (2007) 95-102
15. Portanova J.P., et al. Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease. J. Immunol. 141 (1988) 3370-3376
16. Pals S.T., et al. Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction. J. Immunol. 134 (1985) 1475-1482
17. Gelpi C., et al. Murine graft vs host disease. A model for study of mechanisms that generate autoantibodies to ribonucleoproteins. J. Immunol. 140 (1988) 4160-4166
18. Lang T.J., et al. Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J. Immunol. 171 (2003) 5795-5801
19. Foster, A. et al. (2010) Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOShi host CD4 T cells and IL-21 expression. Clin. Immunol. In press
20. Via C.S., et al. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J. Immunol. 139 (1987) 1840-1849
21. De Wit D., et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150 (1993) 361-366
22. Morris S.C., et al. Experimental induction of systemic lupus erythematosus by recognition of foreign Ia. Clin. Immunol. Immunopathol. 57 (1990) 263-273
23. Rolink A.G., and Gleichmann E. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J. Exp. Med. 158 (1983) 546-558
24. Rus V., et al. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity. J. Immunol. 178 (2007) 3962-3972
25. Van Rappard-Van Der Veen F.M., et al. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. J. Immunol. 130 (1983) 2693-2701
26. Gelpi C., et al. Different strains of donor parental lymphoid cells induce different models of chronic graft-versus-host disease in murine (Balb/c x A/J)F1 hybrid hosts. Clin. Immunol. Immunopathol. 56 (1990) 298-310
27. Tschetter J.R., et al. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J. Immunol. 165 (2000) 5987-5994
28. Reeves W.H., et al. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 30 (2009) 455-464
29. Niculescu F., et al. Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease. Exp. Mol. Pathol. 79 (2005) 136-145
30. Zielinski C.E., et al. Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation. J. Immunol. 174 (2005) 5100-5109
31. Steinberg A.D., et al. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J. Immunol. 125 (1980) 871-873
32. Seaman W.E., et al. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease. J. Immunol. 130 (1983) 1713-1718
33. Santoro T.J., et al. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167 (1988) 1713-1718
34. Jevnikar A.M., et al. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179 (1994) 1137-1143
35. Peng S.L., et al. Murine lupus in the absence of alpha beta T cells. J. Immunol. 156 (1996) 4041-4049
36. Rozzo S.J., et al. Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. J. Immunol. 153 (1994) 1340-1351
37. Rolink A.G., et al. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. J. Exp. Med. 157 (1983) 755-771
38. Busser B.W., et al. Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance. J. Clin. Invest. 112 (2003) 1361-1371
39. Sobel E.S., et al. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J. Immunol. 152 (1994) 6011-6016
40. Hoffman R., and Maldanado M.E. T-cells and systemic lupus erythematosus. In: Tsokos G.C., et al. (Ed). Systemic Lupus Erythematosus: A Companion to Rheumatology (2007), Mosby 95-102
41. Molina J.F., et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J. Rheumatol. 22 (1995) 347-350
42. Drake W.P., et al. Reactivation of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for acquired immunodeficiency syndrome. J. Clin. Rheumatol. 9 (2003) 176-180
43. Davidson A., et al. Block and tackle: CTLA4Ig takes on lupus. Lupus 14 (2005) 197-203
44. Via C.S., et al. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J. Immunol. 157 (1996) 4258-4267
45. Jancin B. SLE drug pipeline: an embarrasment of riches. Rheumatol. News 7 (2008) 12
46. Hannahs Hahn B., and Tsao B.P. Pathogenesis of systemic lupus erythematosus. In: Firestein G., et al. (Ed). Firestein: Kelley's Textbook of Rheumatology (2008), W. B. Saunders 1186-1188 chapt. 74
47. Crispin J.C., et al. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends Immunol. 29 (2008) 110-115
48. Via C.S., and Shearer G.M. Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus. Autoimmunity 43 (2010) 23-31
49. Via C.S., and Shearer G.M. Functional heterogeneity of L3T4+ T cells in MRL-lpr/lpr mice. L3T4+ T cells suppress major histocompatibility complex-self-restricted L3T4+ T helper cell function in association with autoimmunity. J. Exp. Med. 168 (1988) 2165-2181
50. Via C.S., et al. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects. J. Immunol. 151 (1993) 3914-3922
51. Bermas B.L., et al. T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J. Clin. Immunol. 14 (1994) 169-177
52. Kaplan M.J. Apoptosis in systemic lupus erythematosus. Clin. Immunol. 112 (2004) 210-218
53. Casciola-Rosen L.A., et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179 (1994) 1317-1330
54. Peterson L.S., and Winchester R. Systemic lupus erythematosus: pathogenesis. In: Koopman W.J., and Moreland L.W. (Eds). Arthritis & Allied Conditions (2005), Lippincott Williams & Wilkins 1523-1559
55. Via C.S., et al. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J. Immunol. 153 (1994) 4040-4047
56. Lang T.J., et al. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J. Immunol. 168 (2002) 3786-3792
57. Shustov A., et al. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. J. Immunol. 161 (1998) 2848-2855
58. Shustov A., et al. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J. Clin Invest. 106 (2000) R39-R47
59. Via C.S., et al. A major role for the Fas pathway in acute graft-versus-host disease. J. Immunol. 157 (1996) 5387-5393
60. Williams E.L., et al. Anti-TNF-induced lupus. Rheumatology 48 (2009) 716-720
61. Via C.S., et al. In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. J. Immunol. 167 (2001) 6821-6826
62. FDA (2009) Information for Healthcare Professionals: Tumor Necrosis Factor (TNF) Blockers (Marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi). U.S. Department of Health & Human Services
63. Murphy W.J., et al. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses. J. Immunol. 170 (2003) 2727-2733
64. Lode H.N., et al. Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction. J. Clin. Invest. 105 (2000) 1623-1630
65. Bourgeois C., et al. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297 (2002) 2060-2063
66. Rathmell J.C., et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376 (1995) 181-184
67. Bossu P., et al. Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J. Immunol. 151 (1993) 7233-7239
68. Puliaeva I., et al. Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses. J. Immunol. 181 (2008) 5912-5929
69. Peng S.L., et al. Perforin protects against autoimmunity in lupus-prone mice. J. Immunol. 160 (1998) 652-660
70. Blanco P., et al. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 201-211
71. Ronnblom L., et al. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 408-420
72. Horwitz D.A., et al. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin. Immunol. 16 (2004) 135-143
73. La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus 17 (2008) 421-425
74. Zheng S.G., et al. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 172 (2004) 1531-1539
75. Kim J., et al. Maintenance of CD8+ T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease. Exp. Mol. Med. 38 (2006) 494-501
76. Kim J., et al. Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor. J. Immunol. 176 (2006) 5223-5231
77. Matarese G., et al. Regulatory CD4 T cells: sensing the environment. Trends Immunol. 29 (2008) 12-17